DeciBio
Rebecca Bair has a diverse background in the life science industry, starting as an undergraduate researcher at the University of California, Berkeley with a focus on Mycobacterium tuberculosis biology and drug resistance. Rebecca also has experience as a Staff Research Associate at the University of California, San Francisco working in the Clinical Neuroimmunology field. Rebecca has also worked as an ATP Analyst at EVEXIA Bio Fund, where Rebecca performed scientific diligence and financial analysis on biotech companies. With their background in molecular and cell biology, specifically in neurobiology, Rebecca's roles as a Life Science Analyst at DeciBio Consulting highlight their expertise in providing strategic insights for the personalized medicine industry.
DeciBio
1 followers
DeciBio Consulting is a boutique strategy consulting firm focusing on the life science industry. DeciBio's mission is to provide the strategic insights that accelerate the development, adoption, and accessibility of personalized medicine. Headquartered in Los Angeles, CA, DeciBio serves clients and customers across the globe, ranging from incubator-stage startups to Fortune 500 life science corporations. DeciBio addresses business solutions that range from market landscape analyses to full commercial strategies, including organic and inorganic growth opportunities (commercial due diligences). DeciBio’s work is typically supported by a mix of primary and secondary research leveraging Dexter, its in-house expert network, and DeciBio Analytics’ proprietary data intelligence products. DeciBio’s Analytics division offers numerous data products to support strategic insights, including in clinical diagnostics (the DxBooks), immuno-oncology (the I/O BioMAP), omics market segmentation (the MarketBooks), and the entire life sciences industry (BioTrack). Internal teams such as the Culture Committee, Women* in Consulting, and Gays in Consulting enrich the employee experience. DeciBio’s Social Impact board and the DeciBio Impact Lab work collaboratively across divisions and externally to uproot discrimination and increase access to precision medicine.